October 21, 2016 12:39 PM ET


Company Overview of Convergence Pharmaceuticals Limited

Company Overview

Convergence Pharmaceuticals Limited engages in the development of analgesics for the treatment of chronic pain. It offers CNV1014802, a small molecule state-dependent sodium channel blocker that exhibits potency and selectivity against the Nav1.7 sodium channel; and CNV1061436, a Phase I ready sodium channel blocker for the treatment of CNS disorders, including epilepsy and bipolar disorder. The company was founded in 2010 and is based in Cambridge, United Kingdom. As of February 12, 2015, Convergence Pharmaceuticals Limited operates as a subsidiary of Biogen Inc.

Maia Building

Babraham Research Campus

Cambridge,  CB22 3AT

United Kingdom

Founded in 2010


44 1223 755 501


44 1223 497 114

Key Executives for Convergence Pharmaceuticals Limited

Chief Operating Officer
Head of Chemistry and Pre-Clinical Development
Head of Clinical Operations
Head of Biology and Vice President
Medical Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Convergence Pharmaceuticals Limited, please visit www.convergencepharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.